ALAMEDA, Calif., Jul 13, 2001 (BUSINESS WIRE) -- Calypte Biomedical Corporation
(OTC Bulletin Board: CALY) announced that it has received a determination on its
delisting hearing before Nasdaq Listing Qualifications Panel.
Nasdaq has informed Calypte that the company's common stock will no longer be
listed on the Nasdaq SmallCap Market effective Friday July 13, 2001. The
Company's common stock will now trade on the Over The Counter Bulletin Board
under the same stock symbol.
In early March the company received notice from Nasdaq that it had failed to
comply with certain requirements for continued listing on the Nasdaq SmallCap
Market and would be potentially delisted, to which the company had responded
with a request for a hearing before the Nasdaq Listing Qualifications Panel.
This delisting was a result of the company's inability to meet the net tangible
assets and the minimum bid price requirements for continued listing on the
SmallCap Market.
Bin mal eingestiegen zu 0.26 USD...
Bekomme bestimmt Haue von Kicky....*g*
(OTC Bulletin Board: CALY) announced that it has received a determination on its
delisting hearing before Nasdaq Listing Qualifications Panel.
Nasdaq has informed Calypte that the company's common stock will no longer be
listed on the Nasdaq SmallCap Market effective Friday July 13, 2001. The
Company's common stock will now trade on the Over The Counter Bulletin Board
under the same stock symbol.
In early March the company received notice from Nasdaq that it had failed to
comply with certain requirements for continued listing on the Nasdaq SmallCap
Market and would be potentially delisted, to which the company had responded
with a request for a hearing before the Nasdaq Listing Qualifications Panel.
This delisting was a result of the company's inability to meet the net tangible
assets and the minimum bid price requirements for continued listing on the
SmallCap Market.
Bin mal eingestiegen zu 0.26 USD...
Bekomme bestimmt Haue von Kicky....*g*
Text zur Anzeige gekürzt. Gesamten Beitrag anzeigen »
